Socket Graft Injectable

  • For use when all 4 bony walls are intact after extraction
  • Dual phase calcium phosphate based synthetic bone graft material
  • Designed to treat the extraction socket, retain alveolar bone, and resorb quickly and completely
Socket Graft Injectable
This graft material is contained in a sterile, single-use syringe and should be stored in the refrigerator until use. No mixing required.
This product contains no human or animal tissue.
INSURANCE CODES
D7953 Bone Replacement Graft (Socket Graft)
4267 GTR-Non-Resorbable Membrane
Implant Placement in 8 Weeks with Predictable Results
This material regenerates bone while it completely resorbs and becomes replaced by your patient’s own bone. A healthier bone regeneration sequence allows for an implant to be placed sooner than if other bone grafts were used. Implant placement at 8 weeks can now be achieved with predictable results.
SL Factor
Socket Graft Injectable provides the organic and inorganic molecules a bone needs in order to regrow faster, stronger, healthier, and more vital.
Our patented SL Factor in our bone graft material targets the osteoblasts within the patient’s bone, initiating the bone regeneration process. Our product has been classified as a drug device and this the drug contained in this product has been shown to stimulate bone formation.
SteinerBio has the only bone grafts on the market that contain a drug that changes the physiology of a bone’s osteoblasts to stimulate osteogenesis. SL Factor, our patented organic compound, enters through the membrane of the osteoblasts and results in the following metabolic activities:
  • SL Factor is absorbed by the osteoblasts
  • SL Factor activates over 300 genes that stimulate the process of bone formation
  • BMP2 and RUNX2 production increases two-fold and reduces osteoclast formation by inhibiting the production of RANK ligand
  • Osteocalcin accumulation is enhanced in the extracellular matrix resulting in excellent mineralization
  • While stored in the osteoblast, SL Factor continues to stimulate bone growth after the synthetic matrix has been resorbed
  • Adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression is inhibited
  • Inflammation is reduced by inhibiting prostaglandin synthesis